- Home
- VCIC vs OABI Comparison
VCIC vs OABI Comparison
Compare VCIC & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCIC
- OABI
- Stock Information
- Founded
- VCIC 2024
- OABI 2012
- Country
- VCIC United States
- OABI United States
- Employees
- VCIC N/A
- OABI N/A
- Industry
- VCIC
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- VCIC
- OABI Health Care
- Exchange
- VCIC NYSE
- OABI Nasdaq
- Market Cap
- VCIC 304.0M
- OABI 250.8M
- IPO Year
- VCIC 2024
- OABI N/A
- Fundamental
- Price
- VCIC $10.41
- OABI $2.10
- Analyst Decision
- VCIC
- OABI Strong Buy
- Analyst Count
- VCIC 0
- OABI 3
- Target Price
- VCIC N/A
- OABI $7.00
- AVG Volume (30 Days)
- VCIC 12.5K
- OABI 636.1K
- Earning Date
- VCIC 01-01-0001
- OABI 08-06-2025
- Dividend Yield
- VCIC N/A
- OABI N/A
- EPS Growth
- VCIC N/A
- OABI N/A
- EPS
- VCIC N/A
- OABI N/A
- Revenue
- VCIC N/A
- OABI $26,744,000.00
- Revenue This Year
- VCIC N/A
- OABI N/A
- Revenue Next Year
- VCIC N/A
- OABI $45.02
- P/E Ratio
- VCIC $78.14
- OABI N/A
- Revenue Growth
- VCIC N/A
- OABI 27.07
- 52 Week Low
- VCIC $9.96
- OABI $1.22
- 52 Week High
- VCIC $10.74
- OABI $4.96
- Technical
- Relative Strength Index (RSI)
- VCIC N/A
- OABI 62.35
- Support Level
- VCIC N/A
- OABI $1.90
- Resistance Level
- VCIC N/A
- OABI $2.19
- Average True Range (ATR)
- VCIC 0.00
- OABI 0.14
- MACD
- VCIC 0.00
- OABI 0.00
- Stochastic Oscillator
- VCIC 0.00
- OABI 55.48
About VCIC VINE HILL CAP INVT CORP
Vine Hill Capital Investment Corp is a blank check company.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.